Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 20/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL759520 | 1.00 | SLC6A9 (0.80) | SLC6A9 | |
| SCHEMBL3562554 | 0.91 | SLC6A9 (0.86) | SLC6A9 | |
| SCHEMBL3559951 | 0.90 | SLC6A9 (0.85) | SLC6A9 | |
| SCHEMBL759356 | 0.90 | SLC6A9 (0.83) | SLC6A9 | |
| SCHEMBL3559341 | 0.89 | SLC6A9 (0.82) | SLC6A9 | |
| SCHEMBL3558613 | 0.89 | SLC6A9 (1.00) | SLC6A9 | |
| SCHEMBL13037359 | 0.87 | SLC6A9 (0.81) | SLC6A9 | |
| SCHEMBL5042121 | 0.84 | SLC6A9 (0.57) | SLC6A9 | |
| SCHEMBL3557939 | 0.84 | SLC6A9 (1.00) | SLC6A9 | |
| SCHEMBL8278427 | 0.84 | SLC6A9 (0.91) | SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7834031-B2 | Radiolabeled glycine transporter inhibitors | MERCK SHARP & DOHME CORP. (US) | 2010-11-16 | — | — | US | disclosed |
| US-20090269278-A1 | Radiolabeled Glycine Trasporter Inhibitors | MERCK SHARP & DOHME LLC | 2009-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090269278-A1 | Radiolabeled Glycine Trasporter Inhibitors | SLC6A5, SLC1A5, SLC1A3 | SLC6A9 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.